ACHIEVE LIFE SCIENCES, INC. Quarterly Common Stock, Shares Authorized from Q4 2010 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
The maximum number of common shares permitted to be issued by an entity's charter and bylaws.
Summary
Achieve Life Sciences, Inc. quarterly Common Stock, Shares Authorized history and growth rate from Q4 2010 to Q3 2024.
  • Achieve Life Sciences, Inc. Common Stock, Shares Authorized for the quarter ending September 30, 2024 was 150M shares, unchanged year-over-year.
Common Stock, Shares Authorized, Quarterly (shares)
Common Stock, Shares Authorized, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 150M 0 0% Sep 30, 2024 10-Q 2024-11-07
Q2 2024 150M 0 0% Jun 30, 2024 10-Q 2024-08-13
Q1 2024 150M 0 0% Mar 31, 2024 10-Q 2024-05-09
Q4 2023 150M 0 0% Dec 31, 2023 10-Q 2024-11-07
Q3 2023 150M 0 0% Sep 30, 2023 10-Q 2023-11-09
Q2 2023 150M 0 0% Jun 30, 2023 10-Q 2023-08-14
Q1 2023 150M 0 0% Mar 31, 2023 10-Q 2023-05-09
Q4 2022 150M 0 0% Dec 31, 2022 10-K 2024-03-28
Q3 2022 150M 0 0% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 150M 0 0% Jun 30, 2022 10-Q 2022-08-11
Q1 2022 150M 0 0% Mar 31, 2022 10-Q 2022-05-12
Q4 2021 150M 0 0% Dec 31, 2021 10-K 2023-03-16
Q3 2021 150M 0 0% Sep 30, 2021 10-Q 2021-11-09
Q2 2021 150M 0 0% Jun 30, 2021 10-Q 2021-08-12
Q1 2021 150M 0 0% Mar 31, 2021 10-Q 2021-05-13
Q4 2020 150M 0 0% Dec 31, 2020 10-K 2022-03-10
Q3 2020 150M 0 0% Sep 30, 2020 10-Q 2020-11-12
Q2 2020 150M 0 0% Jun 30, 2020 10-Q 2020-08-06
Q1 2020 150M 0 0% Mar 31, 2020 10-Q 2020-05-14
Q4 2019 150M 0 0% Dec 31, 2019 10-K 2021-03-11
Q3 2019 150M 0 0% Sep 30, 2019 10-Q 2019-11-06
Q2 2019 150M 0 0% Jun 30, 2019 10-Q 2019-08-08
Q1 2019 150M +75M +100% Mar 31, 2019 10-Q 2019-05-15
Q4 2018 150M 0 0% Dec 31, 2018 10-K 2020-03-13
Q3 2018 150M +75M +100% Sep 30, 2018 10-Q 2018-11-07
Q2 2018 150M +75M +100% Jun 30, 2018 10-Q 2018-08-08
Q1 2018 75M 0 0% Mar 31, 2018 10-Q 2018-05-09
Q4 2017 150M +75M +100% Dec 31, 2017 10-K 2019-03-14
Q3 2017 75M 0 0% Sep 30, 2017 10-Q 2017-11-09
Q2 2017 75M 0 0% Jun 30, 2017 10-Q 2017-07-31
Q1 2017 75M 0 0% Mar 31, 2017 10-Q 2017-05-15
Q4 2016 75M 0 0% Dec 31, 2016 10-K 2018-03-01
Q3 2016 75M 0 0% Sep 30, 2016 10-Q 2016-11-10
Q2 2016 75M 0 0% Jun 30, 2016 10-Q 2016-08-04
Q1 2016 75M +25M +50% Mar 31, 2016 10-Q 2016-05-12
Q4 2015 75M 0 0% Dec 31, 2015 10-K 2017-02-23
Q3 2015 75M +25M +50% Sep 30, 2015 10-Q 2015-11-12
Q2 2015 75M +25M +50% Jun 30, 2015 10-Q 2015-08-13
Q1 2015 50M 0 0% Mar 31, 2015 10-Q 2015-05-14
Q4 2014 75M +25M +50% Dec 31, 2014 10-K 2016-03-09
Q3 2014 50M 0 0% Sep 30, 2014 10-Q 2014-10-30
Q2 2014 50M 0 0% Jun 30, 2014 10-Q 2014-08-07
Q1 2014 50M +25M +100% Mar 31, 2014 10-Q 2014-04-30
Q4 2013 50M +25M +100% Dec 31, 2013 10-K 2015-03-26
Q3 2013 50M +25M +100% Sep 30, 2013 10-Q 2013-11-07
Q2 2013 50M +25M +100% Jun 30, 2013 10-Q 2013-08-08
Q1 2013 25M 0 0% Mar 31, 2013 10-Q 2013-05-02
Q4 2012 25M 0 0% Dec 31, 2012 10-K 2014-03-11
Q3 2012 25M 0 0% Sep 30, 2012 10-Q 2012-11-08
Q2 2012 25M 0 0% Jun 30, 2012 10-Q 2012-08-02
Q1 2012 25M Mar 31, 2012 10-Q 2012-05-03
Q4 2011 25M 0 0% Dec 31, 2011 10-K 2013-03-07
Q3 2011 25M Sep 30, 2011 10-Q 2011-11-03
Q2 2011 25M Jun 30, 2011 10-Q 2011-08-05
Q4 2010 25M Dec 31, 2010 10-K 2012-03-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.